Which molecular targets do we need to focus on to improve lower urinary tract dysfunction? ICI-RS 2017

Karl-Erik Andersson; Christopher Fry; Jalesh Panicker; Kevin Rademakers

doi:10.1002/nau.23516

Which molecular targets do we need to focus on to improve lower urinary tract dysfunction? ICI-RS 2017

Karl-Erik Andersson, Christopher Fry, Jalesh Panicker, Kevin Rademakers

Research output: Contribution to journal › Review article › Academic › peer-review

Original language	English
Pages (from-to)	S117-S126
Number of pages	10
Journal	Neurourology and Urodynamics
Volume	37
DOIs	https://doi.org/10.1002/nau.23516
Publication status	Published - 1 Jun 2018

Keywords

ATP
bladder
cannabinoids
CNS
fibrosis
prostanoids
urethra
BLADDER OVERACTIVITY
RECEPTOR ANTAGONIST
BOMBESIN RECEPTORS
PROSTAGLANDIN E-2
DETRUSOR MUSCLE
NEURAL-CONTROL
EP3 RECEPTORS
RAT MODEL
ADENOSINE
DISEASE

Cite this

Andersson, K-E., Fry, C., Panicker, J., & Rademakers, K. (2018). Which molecular targets do we need to focus on to improve lower urinary tract dysfunction? ICI-RS 2017. Neurourology and Urodynamics, 37, S117-S126. https://doi.org/10.1002/nau.23516

@article{3cc9e7a05c2447cb93a9e06a37534a8d,

title = "Which molecular targets do we need to focus on to improve lower urinary tract dysfunction? ICI-RS 2017",

keywords = "ATP, bladder, cannabinoids, CNS, fibrosis, prostanoids, urethra, BLADDER OVERACTIVITY, RECEPTOR ANTAGONIST, BOMBESIN RECEPTORS, PROSTAGLANDIN E-2, DETRUSOR MUSCLE, NEURAL-CONTROL, EP3 RECEPTORS, RAT MODEL, ADENOSINE, DISEASE",

author = "Karl-Erik Andersson and Christopher Fry and Jalesh Panicker and Kevin Rademakers",

year = "2018",

month = jun,

day = "1",

doi = "10.1002/nau.23516",

language = "English",

volume = "37",

pages = "S117--S126",

journal = "Neurourology and Urodynamics",

issn = "0733-2467",

publisher = "Wiley",

}

TY - JOUR

T1 - Which molecular targets do we need to focus on to improve lower urinary tract dysfunction? ICI-RS 2017

AU - Andersson, Karl-Erik

AU - Fry, Christopher

AU - Panicker, Jalesh

AU - Rademakers, Kevin

PY - 2018/6/1

Y1 - 2018/6/1

KW - ATP

KW - bladder

KW - cannabinoids

KW - CNS

KW - fibrosis

KW - prostanoids

KW - urethra

KW - BLADDER OVERACTIVITY

KW - RECEPTOR ANTAGONIST

KW - BOMBESIN RECEPTORS

KW - PROSTAGLANDIN E-2

KW - DETRUSOR MUSCLE

KW - NEURAL-CONTROL

KW - EP3 RECEPTORS

KW - RAT MODEL

KW - ADENOSINE

KW - DISEASE

U2 - 10.1002/nau.23516

DO - 10.1002/nau.23516

M3 - Review article

VL - 37

SP - S117-S126

JO - Neurourology and Urodynamics

JF - Neurourology and Urodynamics

SN - 0733-2467

ER -

Access to Document

10.1002/nau.23516